Clinical Trials Browser

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

Ann Arbor Stage II Mantle Cell Lymphoma

Uterine Cervical Neoplasms

Urinary Bladder Neoplasms

Thymic epithelial tumor, Mediastinal Neoplasms, Thymoma

Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

Esophageal Squamous Cell Carcinoma

Carcinoma, Non-Small-Cell Lung

Advanced Squamous Non-Small Cell Lung Cancer

Ovarian Neoplasms

Mesothelioma, Malignant

Esophageal Squamous Cell Carcinoma

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck

Biliary Tract Neoplasms

Non Squamous Non-small Cell Lung Cancer

Nasopharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

Advanced Biliary Tract Cancer(BTC)

Squamous Cell Carcinoma of Head and Neck

Nasopharyngeal Neoplasms

Carcinoma, Non-Small-Cell Lung

Lymphatic Metastasis

Liver Neoplasms

HER2-positive Gastric Cancer

Sarcoma, Ewing, Osteosarcoma

Clinical Trials

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

TRIFECTA

6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors

QLS5132 Combination Therapy in Advanced Solid Tumors

Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC

FANLUNG-2：The Value of High-Low Mixed-Dose Radiotherapy Combined With Chemo-Immunotherapy Induction in Locally Advanced Non-Small Cell Lung Cancer

CECYDE

Iparomlimab and Tuvonralimab (QL1706) Combined With Standard Chemotherapy or Combined With Intraperitoneal Perfusion Chemotherapy and Olaparib as Neoadjuvant Therapy for Advanced Ovarian Cancer

LAG-MAPS

Short-course Radiotherapy Combined With Serplulimab and Chemotherapy as Neoadjuvant Treatment for Resectable ESCC

Intralesional Chemotherapy (IC): Cisplatin + Epinephrine

Neoadjuvant Becotatug Vedotin Plus Pucotenlimab and Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma

Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer

Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer

Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma

PDT For Induction Therapy For Head And Neck Cancer

NOBLE

SHINE

Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma

TeLuRide-008

Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC

Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma

A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma